Dr. Plante obtained her medical degree from Laval University in 1985 and completed her residency in obstetrics and gynecology at McGill University in 1990. She continued with a 3-year subspecialty in gynecologic oncology at the Memorial Sloan-Kettering Cancer Center in New York in 1993. Since then, she has worked as a gynecologist-oncologist at l’Hôtel-Dieu de Québec.

Dr. Plante is a Professor in the Department of Obstetrics and Gynecology at Laval University. She is head of the oncology-gynecology department and in charge of clinical research at l’Hôtel-Dieu de Québec.


  1. Plante is best known for her expertise in minimally invasive surgery in the treatment of gynecological cancers, including robot-assisted surgery, the sentinel lymph node technique in gynecological cancers and in surgeries aimed at preserving fertility in young women suffering from cervical cancer, including radical trachelectomy.
  2. Plante is the principal investigator of a large international, prospective and randomized study led by the Canadian Cancer Trials Group (CCTG) and the Gynecologic Cancer InterGroup (GCIG) (CX-5 or SHAPE study). The study aims to randomize patients with early-stage and low-risk cervical cancer to receive either radical hysterectomy (standard) or simple hysterectomy (studied). More than 700 patients will be randomized in this study.
  3. In addition, Dr. Plante is particularly interested in oncogenetics related to ovarian cancer. She has been involved in the activities of the oncogenetics department, along with the St-Sacrement Hospital team, since its inception, and is responsible for its ovarian component.

Recent Appointments

  1. Co-chair of CCRN (Cervical Cancer Research Network)
  2. Chair, International Committee, SGO (Society of Gynecologic Oncology)
  3. Co-chair, Cervix Working Group, CCTG
  4. Member, Editorial Board, International Journal of Gynecologic Cancer (IJGC) and Journal of Obstetrics and Gynecology of Canada (JOGC)
L'Hôtel-Dieu de Québec
11, côte du Palais
Québec, Québec
Canada G1R 2J6

Latest news

Data not available

155 entries « 16 of 16 »

Vallée MH, Rouleau I, Chiquette J, Plante M, Simard J, Dorval M

HRT use among women tested for BRCA1/2 mutations following publication of the women's health initiative study results.

Journal Article

J Obstet Gynaecol Can, 27 (4), pp. 321; author reply 322, 2005, ISSN: 1701-2163.

| Links:

Dube V, Roy M, Plante M, Renaud MC, Tetu B

Mucinous ovarian tumors of Mullerian-type: an analysis of 17 cases including borderline tumors and intraepithelial, microinvasive, and invasive carcinomas.

Journal Article

Int J Gynecol Pathol, 24 (2), pp. 138-46, 2005, ISSN: 0277-1691.

Abstract | Links:

Riopel J, Plante M, Renaud MC, Roy M, Tetu B

Lymph node metastases in low-grade endometrial stromal sarcoma.

Journal Article

Gynecol Oncol, 96 (2), pp. 402-6, 2005, ISSN: 0090-8258.

Abstract | Links:

Godard B, Simard J, INHERIT BRCAs

Les enjeux éthiques de l'identification d'une susceptibilité génétique au cancer du sein dans un contexte de recherche clinique intégrée

Book Chapter

C, Hervé; BM, Knoppers; PA, Molinari (Ed.): Les pratiques de recherche biomédicale visitées par la bioéthique, pp. 113-136, Paris, Dalloz, 2003, ISBN: 2247050697.

Dewailly E, Beuter A, Plante M, Ayotte P, Bruneau S, Mirault ME, Grey M, Weber JP

Mercury in Salluit : effects of mercury on oxydative [sic] status and sensorimotor functions

Book Chapter

Synopsis of research conducted under the 2001-2003 Northern Contaminants Program, pp. 73-85, Ottawa, Dept. of Indian Affairs and Northern Development, 2003, 2003.

155 entries « 16 of 16 »
Signaler des ajouts ou des modifications

Active projects

  • Centre de recherche du CHU de Québec - Université Laval, Subvention, Centre hospitalier universitaire de Québec - Université Laval, Centres de recherche affiliés, from 2017-01-01 to 2099-12-31
  • Centre de recherche sur le cancer, Subvention, Institutionnel - BDR, BDR - Centres de recherche reconnus, from 1996-05-01 to 2022-06-13

Recently finished projects

  • Randomized trial comparing radical hysterectomy and pelvic node dissection vs simple hysterectomy and pelvic node dissection in patients with low risk cervical cancer defined as lesions measuring less than 2 cm with less than 50% stromal in, Subvention, Instituts de recherche en santé du Canada, Subvention de fonctionnement, from 2012-03-31 to 2020-03-31
Data provided by the Université Laval research projects registery